During the past decade, Coastal Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coastal Cancer Center" #1 sponsor was "Duke University" with 2 trials, followed by "National Cancer Institute (NCI)" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Coherus Biosciences, Inc." with 1 trials sponsored and "Fox Chase Cancer Center" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Cancer Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Community Clinical Oncology Research Network, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Coastal Cancer Center" are "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Estrogen Receptor Negative" (1 trials), "Estrogen Receptor Positive" (1 trials) and "Febrile Neutropenia" (1 trials). Many other conditions were trialed in "Coastal Cancer Center" in a lesser frequency.

Most popular intervention types in "Coastal Cancer Center" are "Drug" (9 trials), "Biological" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Bevacizumab" (1 trials), "Cisplatin & Gemcitabine" (1 trials), "Cisplatin & Pemetrexed" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Coastal Cancer Center" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Coastal Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Coastal Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Coastal Cancer Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".